Ying Zhu, Kun-Bin Ke, Zhong-Kun Xia, Hong-Jian Li, Rong Su, Chao Dong, . . . Marie Chia-mi Lin. (2021). Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma. BMC.
Chicago Style (17th ed.) CitationYing Zhu, et al. Discovery of Vanoxerine Dihydrochloride as a CDK2/4/6 Triple-inhibitor for the Treatment of Human Hepatocellular Carcinoma. BMC, 2021.
MLA (9th ed.) CitationYing Zhu, et al. Discovery of Vanoxerine Dihydrochloride as a CDK2/4/6 Triple-inhibitor for the Treatment of Human Hepatocellular Carcinoma. BMC, 2021.
Warning: These citations may not always be 100% accurate.